‘His & Hers’ Adds Izzy Kusma, Jamie Tisdale, Rhoda Griffis & Dave Maldonado Among 10 To Recur
Izzy Kusma, Jamie Tisdale, Rhoda Griffis and Dave Maldonado are among 10 actors to recur on Netflix's limited series His & ...
Mark Zuckerberg and Wife Priscilla Cause Stir With 'His and Hers' Cars
Zuckerberg and his wife, Priscilla Chan, have three young children, and he told fans on Instagram that she wanted a minivan ...
Jacob Elordi and Olivia Jade Do His-and-Hers Bottega Bags
Do you think Elordi and Olivia share a bag wardrobe—and coordinate who will carry which one pre-flight? And does Elordi have ...
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...
Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List
Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs ...
4-Hers attend livestock encampment at state fair
This year, 60 4-H members from Mower County attended the livestock encampment at the Minnesota State Fair. 4-H members participate in the county fair and State Fair to showcase the knowledge and ...
Another Today Exit Was Allegedly Coming Before Hoda Announced Hers. Now NBC Is Apparently Hanging On Tightly
Had the Dateline NBC vet not gone public with her decision to vacate her Today spot, Hoda Kotb might have been the one ...
For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away
Hims & Hers shares tanked after regulators signaled new limits on the production of versions of weight-loss drugs.
Hims & Hers Health Stock Is Rising Monday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...
These Stocks Are Moving the Most Today: Tesla, Levi Strauss, Humana, Hims & Hers, Nvidia, Stellantis, and More
Tesla extends losses following the release of third-quarter deliveries, and Levi Strauss tumbles after cutting its ...
Hims & Hers: Shortage Saga Brings Stupendous Risk-Reward
Anticipating a 35% CAGR in 2025, Hims & Hers is poised for substantial growth. Read why I maintain my strong buy rating on ...
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...